Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. (2014)

First Author: 3C Study Collaborative Group
Attributed to:  CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)61095-3

PubMed Identifier: 25078310

Publication URI: http://europepmc.org/abstract/MED/25078310

Type: Journal Article/Review

Volume: 384

Parent Publication: Lancet (London, England)

Issue: 9955

ISSN: 0140-6736